NEOMYCIN SULFATE and RASH

Overview

RASH is the #9 most commonly reported adverse reaction for NEOMYCIN SULFATE, manufactured by Total Resources International. There are 230 FDA adverse event reports linking NEOMYCIN SULFATE to RASH. This represents approximately 1.9% of all 12,389 adverse event reports for this drug.

Patients taking NEOMYCIN SULFATE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for NEOMYCIN SULFATE, but still significant enough to appear in the safety profile.

Other Side Effects of NEOMYCIN SULFATE

In addition to rash, the following adverse reactions have been reported for NEOMYCIN SULFATE:

• DRUG INEFFECTIVE — 500 reports
• DRUG HYPERSENSITIVITY — 497 reports
• PAIN — 353 reports
• NAUSEA — 319 reports
• DYSPNOEA — 303 reports
• MALAISE — 282 reports
• OFF LABEL USE — 282 reports
• INFUSION RELATED REACTION — 231 reports
• THERAPEUTIC PRODUCT EFFECT INCOMPLETE — 210 reports
• MACULAR DEGENERATION — 201 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does NEOMYCIN SULFATE cause RASH?

RASH has been reported as an adverse event in 230 FDA reports for NEOMYCIN SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with NEOMYCIN SULFATE?

RASH accounts for approximately 1.9% of all adverse event reports for NEOMYCIN SULFATE, making it a notable side effect.

What should I do if I experience RASH while taking NEOMYCIN SULFATE?

If you experience rash while taking NEOMYCIN SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages